NexGel Q2 revenue up 100.3% YoY to $2.88 mln, gross profit 43.6%.

• NEXGEL reports Q2 2025 revenue of $2.88 million, up 100.3% YoY. • Gross profit for the quarter is 43.6%, compared to 20.3% in 2024. • Company reiterates 2025 revenue guidance of $13 million. • Aims to achieve positive EBITDA during the year. • NEXGEL provides healthcare, beauty, and OTC products. • Hydrogel products are ultra-gentle and high-water-content. • Company is headquartered in Langhorne, Pa. • Listed on NASDAQ under the ticker symbol NXGL.

Langhorne, Pa., Aug. 12, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (NASDAQ: NXGL), a leading provider of healthcare, beauty, and over-the-counter (OTC) products, including ultra-gentle, high-water-content hydrogel products, today announced its second quarter 2025 financial results. The company reported a significant increase in revenue and gross profit margin, while reiterating its 2025 revenue guidance and aiming for positive EBITDA during the year.

For the second quarter of 2025, NEXGEL reported net revenue of $2.88 million, a 100.3% year-over-year increase from $1.44 million in the same period of 2024. Gross profit for the quarter was $1.26 million, representing a 43.6% gross profit margin, compared to 20.3% in the same period of 2024. The company attributed the growth to increased sales in both contract manufacturing and branded products.

The company's cost of revenues totaled $1.63 million for the second quarter of 2025, up from $1.15 million in the same period of 2024. Selling, general, and administrative expenses were $1.89 million, compared to $1.27 million in the same period of 2024. The increase in expenses was primarily due to higher compensation and benefits, share-based compensation, and professional and consulting fees.

NEXGEL reported an EBITDA1 loss of $0.53 million for the second quarter of 2025, compared to a loss of $0.76 million in the same period of 2024. Adjusted EBITDA1 was $0.42 million, compared to $0.79 million in the same period of 2024. The company's net loss attributable to NEXGEL stockholders for the second quarter of 2025 was $0.67 million, compared to a net loss of $0.89 million in the same period of 2024.

The company's cash balance as of June 30, 2025, was approximately $0.73 million. Subsequent to the quarter, NEXGEL expanded its partnership with STADA, which includes a $1 million advance in non-dilutive capital to support product launches and marketing efforts. Additionally, the company closed on financings for $1.05 million in gross proceeds.

NEXGEL reiterated its 2025 revenue guidance of $13 million and expects to achieve positive EBITDA during the year. The company anticipates significant growth opportunities in the second half of 2025 as new consumer product launches for its brands come online and it onboards new contract manufacturing customers.

[1] https://ir.nexgel.com/news-events/press-releases/detail/105/nexgel-reports-second-quarter-2025-financial-results